Lynn Norment, a columnist for The Commercial Appeal, is a former editor for Ebony Magazine. It’s not shocking or even surprising that HIV and AIDS are on the rise in today’s world. The dreaded disease ...

News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top HIV drug maker Gilead Sciences last week. But, according to analysts at ...

Protecting public health abroad benefits Americans. In a globalized world, diseases and their social and economic impacts do not stay within national boundaries. Increased rates of untreated HIV in ...

The US Preventive Services Task Force (USPSTF) is expanding its recommendation for antiretrovirals in HIV now that more options are available on the market. "With these new options we could ...

The Pennsylvania Department of Health will cut 25% of funding to the Part B of the Ryan White HIV/AIDS Program amid rising ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Long-acting injectable HIV treatment is approved in the ...

Miguel, a 63-year-old Los Angeles teacher, recently marked the 38th anniversary of his diagnosis with HIV. The doctor had told him he would be dead in a couple of years. He lived fearful that each ...

Women in a growing number of African countries will soon have access to a vaginal ring to help reduce their risk of acquiring HIV from an infected partner. And they can use it discreetly, without ...

For two decades, the dominant idea in HIV research has been that antiretroviral therapy effectively wipes out active viruses that cause devastating infections but leaves behind a reservoir of infected ...

Moving misbranded and adulterated HIV drugs from the black market to retail pharmacies and HIV patients was a $60 million business for a Delray Beach man, the company he ran out of his apartment and ...